302 related articles for article (PubMed ID: 36564831)
1. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
[TBL] [Abstract][Full Text] [Related]
2. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS.
Liu X; Gao X; Zhang R; Liu Z; Shen N; Di Y; Fang T; Li H; Tian F
Clin Biochem; 2020 Aug; 82():40-50. PubMed ID: 32194037
[TBL] [Abstract][Full Text] [Related]
3. Integrating machine learning and nontargeted plasma lipidomics to explore lipid characteristics of premetabolic syndrome and metabolic syndrome.
Huang X; He Q; Hu H; Shi H; Zhang X; Xu Y
Front Endocrinol (Lausanne); 2024; 15():1335269. PubMed ID: 38559697
[TBL] [Abstract][Full Text] [Related]
4. Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
Peddinti G; Cobb J; Yengo L; Froguel P; Kravić J; Balkau B; Tuomi T; Aittokallio T; Groop L
Diabetologia; 2017 Sep; 60(9):1740-1750. PubMed ID: 28597074
[TBL] [Abstract][Full Text] [Related]
5. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
[TBL] [Abstract][Full Text] [Related]
6. Prediction of metabolic and pre-metabolic syndromes using machine learning models with anthropometric, lifestyle, and biochemical factors from a middle-aged population in Korea.
Kim J; Mun S; Lee S; Jeong K; Baek Y
BMC Public Health; 2022 Apr; 22(1):664. PubMed ID: 35387629
[TBL] [Abstract][Full Text] [Related]
7. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis.
She H; Du Y; Du Y; Tan L; Yang S; Luo X; Li Q; Xiang X; Lu H; Hu Y; Liu L; Li T
BMC Anesthesiol; 2023 Nov; 23(1):367. PubMed ID: 37946144
[TBL] [Abstract][Full Text] [Related]
9. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.
Zhang Y; Zhang H; Rong S; Bian C; Yang Y; Pan H
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2449-2457. PubMed ID: 34154888
[TBL] [Abstract][Full Text] [Related]
10. Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants.
Wu Q; Li J; Sun X; He D; Cheng Z; Li J; Zhang X; Xie Y; Zhu Y; Lai M
EBioMedicine; 2021 Dec; 74():103707. PubMed ID: 34801968
[TBL] [Abstract][Full Text] [Related]
11. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
[TBL] [Abstract][Full Text] [Related]
12. Blood Metabolite Signature of Metabolic Syndrome Implicates Alterations in Amino Acid Metabolism: Findings from the Baltimore Longitudinal Study of Aging (BLSA) and the Tsuruoka Metabolomics Cohort Study (TMCS).
Roberts JA; Varma VR; Huang CW; An Y; Oommen A; Tanaka T; Ferrucci L; Elango P; Takebayashi T; Harada S; Iida M; Thambisetty M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070008
[TBL] [Abstract][Full Text] [Related]
13. Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
Lee AM; Hu J; Xu Y; Abraham AG; Xiao R; Coresh J; Rebholz C; Chen J; Rhee EP; Feldman HI; Ramachandran VS; Kimmel PL; Warady BA; Furth SL; Denburg MR;
J Am Soc Nephrol; 2022 Feb; 33(2):375-386. PubMed ID: 35017168
[TBL] [Abstract][Full Text] [Related]
14. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts.
Shi M; Han S; Klier K; Fobo G; Montrone C; Yu S; Harada M; Henning AK; Friedrich N; Bahls M; Dörr M; Nauck M; Völzke H; Homuth G; Grabe HJ; Prehn C; Adamski J; Suhre K; Rathmann W; Ruepp A; Hertel J; Peters A; Wang-Sattler R
Cardiovasc Diabetol; 2023 Jun; 22(1):141. PubMed ID: 37328862
[TBL] [Abstract][Full Text] [Related]
16. A molecular signature for the metabolic syndrome by urine metabolomics.
Bruzzone C; Gil-Redondo R; Seco M; Barragán R; de la Cruz L; Cannet C; Schäfer H; Fang F; Diercks T; Bizkarguenaga M; González-Valle B; Laín A; Sanz-Parra A; Coltell O; de Letona AL; Spraul M; Lu SC; Buguianesi E; Embade N; Anstee QM; Corella D; Mato JM; Millet O
Cardiovasc Diabetol; 2021 Jul; 20(1):155. PubMed ID: 34320987
[TBL] [Abstract][Full Text] [Related]
17. Untargeted plasma metabolome identifies biomarkers in patients with extracranial arteriovenous malformations.
Fan X; Gao X; Deng Y; Ma B; Liu J; Zhang Z; Zhang D; Yang Y; Wang C; He B; Nie Q; Ye Z; Liu P; Wen J
Front Physiol; 2023; 14():1207390. PubMed ID: 37727659
[No Abstract] [Full Text] [Related]
18. Liquid chromatography-mass spectrometry untargeted metabolomics reveals increased levels of tryptophan indole metabolites in urine of metabolic syndrome patients.
Esperanza MG; Wrobel K; Ojeda AG; Garay-Sevilla ME; Escobosa ARC; Barrientos EY; Wrobel K
Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):379-387. PubMed ID: 33295818
[TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers for risk assessment of arsenicosis based on untargeted metabolomics and machine learning algorithms.
Zhang J; Ma L; Li B; Chen X; Wang D; Zhang A
Sci Total Environ; 2023 Apr; 870():161861. PubMed ID: 36716877
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
